During the past decade, Rheumatic Disease Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumatic Disease Associates" #1 sponsor was "Human Genome Sciences Inc." with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Rigel Pharmaceuticals" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatic Disease Associates" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Elan Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rheumatic Disease Associates" are "Rheumatoid Arthritis" (9 trials), "Arthritis, Rheumatoid" (4 trials), "Psoriatic Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Rheumatic Disease Associates" in a lesser frequency.

Most popular intervention types in "Rheumatic Disease Associates" are "Drug" (17 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abatacept" (2 trials), "Belimumab 1 mg/kg" (2 trials), "Belimumab 10 mg/kg" (2 trials) and "Belimumab 4 mg/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rheumatic Disease Associates" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Rheumatic Disease Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Rheumatic Disease Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rheumatic Disease Associates, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".